In continuation of letter dated 18th July, 2025 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Piramal Pharma has informed that it enclosed the transcript of the Conference Call held on 29th July, 2025 on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2025, is available on the Company’s website at https://www.piramalpharma.com/financial-reports.
The above information is a part of company’s filings submitted to BSE.
